BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hristov AC, Tejasvi T, Wilcox RA. Mycosis fungoides and Sézary syndrome: 2019 update on diagnosis, risk-stratification, and management. Am J Hematol 2019;94:1027-41. [PMID: 31313347 DOI: 10.1002/ajh.25577] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 8.7] [Reference Citation Analysis]
Number Citing Articles
1 Zinzani PL, Quaglino P, Violetti SA, Cantonetti M, Goteri G, Onida F, Paulli M, Rupoli S, Barosi G, Pimpinelli N. Critical concepts and management recommendations for cutaneous T-cell lymphoma: A consensus-based position paper from the Italian Group of Cutaneous Lymphoma. Hematol Oncol 2021;39:275-83. [PMID: 33855728 DOI: 10.1002/hon.2832] [Reference Citation Analysis]
2 Wen P, Xie Y, Wang L. The Role of microRNA in Pathogenesis, Diagnosis, Different Variants, Treatment and Prognosis of Mycosis Fungoides. Front Oncol 2021;11:752817. [PMID: 34966672 DOI: 10.3389/fonc.2021.752817] [Reference Citation Analysis]
3 Li H, Wang C, Ma P, Zhang M, Yang H, Yuan S, Wei J, Tao L, Qian K, Xu M, Li L. The retinoid derivant ECPIRM selectively exhibited anti-proliferation effects in cutaneous T-Cell lymphoma via ITK-mediated signaling pathway. J Dermatol Sci 2020;97:208-15. [PMID: 32165081 DOI: 10.1016/j.jdermsci.2020.01.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Stolearenco V, Namini MRJ, Hasselager SS, Gluud M, Buus TB, Willerslev-Olsen A, Ødum N, Krejsgaard T. Cellular Interactions and Inflammation in the Pathogenesis of Cutaneous T-Cell Lymphoma. Front Cell Dev Biol 2020;8:851. [PMID: 33015047 DOI: 10.3389/fcell.2020.00851] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wilhelm R, Eckes T, Imre G, Kippenberger S, Meissner M, Thomas D, Trautmann S, Merlio JP, Chevret E, Kaufmann R, Pfeilschifter J, Koch A, Jäger M. C6 Ceramide (d18:1/6:0) as a Novel Treatment of Cutaneous T Cell Lymphoma. Cancers (Basel) 2021;13:E270. [PMID: 33450826 DOI: 10.3390/cancers13020270] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Patil K, Kuttikrishnan S, Khan AQ, Ahmad F, Alam M, Buddenkotte J, Ahmad A, Steinhoff M, Uddin S. Molecular pathogenesis of Cutaneous T cell Lymphoma: Role of chemokines, cytokines, and dysregulated signaling pathways. Semin Cancer Biol 2021:S1044-579X(21)00296-0. [PMID: 34906723 DOI: 10.1016/j.semcancer.2021.12.003] [Reference Citation Analysis]
7 Zhang P, Zhang M. Epigenetics in the Pathogenesis and Treatment of Cutaneous T-Cell Lymphoma. Front Oncol 2021;11:663961. [PMID: 34249700 DOI: 10.3389/fonc.2021.663961] [Reference Citation Analysis]
8 Bondarev AD, Attwood MM, Jonsson J, Chubarev VN, Tarasov VV, Schiöth HB. Recent developments of HDAC inhibitors: Emerging indications and novel molecules. Br J Clin Pharmacol 2021. [PMID: 33971031 DOI: 10.1111/bcp.14889] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
9 Vadivel CK, Gluud M, Torres-Rusillo S, Boding L, Willerslev-Olsen A, Buus TB, Nielsen TK, Persson JL, Bonefeld CM, Geisler C, Krejsgaard T, Fuglsang AT, Odum N, Woetmann A. JAK3 Is Expressed in the Nucleus of Malignant T Cells in Cutaneous T Cell Lymphoma (CTCL). Cancers (Basel) 2021;13:280. [PMID: 33466582 DOI: 10.3390/cancers13020280] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Jonak C, Tittes J, Brunner PM, Guenova E. Mycosis fungoides and Sézary syndrome. J Dtsch Dermatol Ges 2021;19:1307-34. [PMID: 34541796 DOI: 10.1111/ddg.14610] [Reference Citation Analysis]
11 Scarisbrick JJ, Bagot M, Ortiz-Romero PL. The changing therapeutic landscape, burden of disease, and unmet needs in patients with cutaneous T-cell lymphoma. Br J Haematol 2021;192:683-96. [PMID: 33095448 DOI: 10.1111/bjh.17117] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Patel RP, Thomas JR, Curt KM, Fitzsimmons CM, Batista PJ, Bates SE, Gottesman MM, Robey RW. Dual Inhibition of Histone Deacetylases and the Mechanistic Target of Rapamycin Promotes Apoptosis in Cell Line Models of Uveal Melanoma. Invest Ophthalmol Vis Sci 2021;62:16. [PMID: 34533562 DOI: 10.1167/iovs.62.12.16] [Reference Citation Analysis]
13 Catherine J, Roufosse F. What does elevated TARC/CCL17 expression tell us about eosinophilic disorders? Semin Immunopathol 2021;43:439-58. [PMID: 34009399 DOI: 10.1007/s00281-021-00857-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Bedier H, Lin J, Julien LA, Routy JP. Concurrent development of HIV-negative Kaposi's sarcoma and mycosis fungoides in an elderly Inuit from Canada. BMJ Case Rep 2021;14:e238644. [PMID: 33509877 DOI: 10.1136/bcr-2020-238644] [Reference Citation Analysis]
15 Scheu A, Schnabl SM, Steiner DP, Fend F, Berneburg M, Yazdi AS. Importance of diagnostics and risk of secondary malignancies in primary cutaneous lymphomas. J Dtsch Dermatol Ges 2021;19:373-81. [PMID: 33576187 DOI: 10.1111/ddg.14400] [Reference Citation Analysis]
16 Gluud M, Willerslev-Olsen A, Gjerdrum LMR, Lindahl LM, Buus TB, Andersen MH, Bonefeld CM, Krejsgaard T, Litvinov IV, Iversen L, Becker JC, Persson JL, Koralov SB, Litman T, Geisler C, Woetmann A, Odum N. MicroRNAs in the Pathogenesis, Diagnosis, Prognosis and Targeted Treatment of Cutaneous T-Cell Lymphomas. Cancers (Basel) 2020;12:E1229. [PMID: 32414221 DOI: 10.3390/cancers12051229] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
17 Reneau JC, Wilcox RA. Novel therapies targeting cutaneous T cell lymphomas and their microenvironment. Semin Hematol 2021;58:103-13. [PMID: 33906720 DOI: 10.1053/j.seminhematol.2021.02.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Scheu A, Schnabl SM, Steiner DP, Fend F, Berneburg M, Yazdi AS. Stellenwert diagnostischer Verfahren und Risiko von Zweittumoren bei primär kutanen Lymphomen. J Dtsch Dermatol Ges 2021;19:373-82. [PMID: 33709586 DOI: 10.1111/ddg.14400_g] [Reference Citation Analysis]
19 Szczepiorkowski ZM. Indications for therapeutic apheresis in hematological disorders. Semin Hematol 2020;57:57-64. [PMID: 32892844 DOI: 10.1053/j.seminhematol.2020.07.008] [Reference Citation Analysis]
20 Jonak C, Tittes J, Brunner PM, Guenova E. Mycosis fungoides und Sézary-Syndrom. J Dtsch Dermatol Ges 2021;19:1307-35. [PMID: 34541808 DOI: 10.1111/ddg.14610_g] [Reference Citation Analysis]
21 Barron CR, Smoller BR. Evaluation of Melanocyte Loss in Mycosis Fungoides Using SOX10 Immunohistochemistry. Dermatopathology (Basel) 2021;8:277-84. [PMID: 34287276 DOI: 10.3390/dermatopathology8030034] [Reference Citation Analysis]
22 Brouwer IJ, Out-Luiting JJ, Vermeer MH, Tensen CP. Cucurbitacin E and I target the JAK/STAT pathway and induce apoptosis in Sézary cells. Biochem Biophys Rep 2020;24:100832. [PMID: 33102814 DOI: 10.1016/j.bbrep.2020.100832] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
23 Gan L, Shi H, Zhang Y, Sun J, Chen H. Proteomic Screening and Verification of Biomarkers in Different Stages of Mycosis Fungoides: A pilot Study. Front Cell Dev Biol 2021;9:747017. [PMID: 34966737 DOI: 10.3389/fcell.2021.747017] [Reference Citation Analysis]
24 Stadler R, Scarisbrick JJ. Maintenance therapy in patients with mycosis fungoides or Sézary syndrome: A neglected topic. Eur J Cancer 2021;142:38-47. [PMID: 33217680 DOI: 10.1016/j.ejca.2020.10.007] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Hernández-Coronado M, Gómez-Almaguer D, Jaime-Pérez JC. Haploidentical hematopoietic cell transplantation for mycosis fungoides/ Sezary syndrome using reduced intensity conditioning after brentuximab therapy discontinuation: advantages of an outpatient program in the times of COVID-19. Hematol Transfus Cell Ther 2021:S2531-1379(21)00088-2. [PMID: 34253503 DOI: 10.1016/j.htct.2021.05.005] [Reference Citation Analysis]
26 Dummer R, Vermeer MH, Scarisbrick JJ, Kim YH, Stonesifer C, Tensen CP, Geskin LJ, Quaglino P, Ramelyte E. Cutaneous T cell lymphoma. Nat Rev Dis Primers 2021;7:61. [PMID: 34446710 DOI: 10.1038/s41572-021-00296-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 S Mehta R, Torres Cabala CA, DiNardo CD, Daver N, Dabaja B, Rezvani K, Champlin RE, Shpall E, Duvic M. Post-transplantation donor-derived Sezary syndrome in a patient with A91V PRF1 variant hemophagocytic lymphohistiocytosis. Am J Hematol 2021;96:E350-3. [PMID: 34096089 DOI: 10.1002/ajh.26266] [Reference Citation Analysis]
28 Albanese F, Abramo F, Marino M, Massaro M, Marconato L, Minoli L, Martini V, Aresu L. Feline and Canine Cutaneous Lymphocytosis: Reactive Process or Indolent Neoplastic Disease? Vet Sci 2022;9:26. [PMID: 35051110 DOI: 10.3390/vetsci9010026] [Reference Citation Analysis]